Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Amy W. Schulman

At a glance: Amy W. Schulman is Director at Alnylam Pharmaceuticals (ALNY). Their latest SEC Form 4, filed Nov 12, 2026, reported a purchase of $300K. On file: 1 purchase line ($300K) and 1 sale line ($7K).

Disclosed holdings: about $3.8M of ALNY stock: 25,959 shares reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 20, 2026 close of $147.97. This counts only ALNY shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Alnylam Pharmaceuticals, Inc. (ALNY); Director at Elevance Health, Inc. (ELV)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$17K
Total bought / sold$300K / $7K

Amy W. Schulman's InsiderPrint

5 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.

InsiderPrint of Amy W. Schulman: 5 trades, 2020 to 20262020: 1 buy, 0 sales2021: 1 buy, 0 sales2022: 0 buys, 0 sales2023: 0 buys, 0 sales2024: 0 buys, 0 sales2025: 1 buy, 0 sales2026: 1 buy, 1 sale

Reading this print: Mostly buys, trading about once a year, typically $20K a trade; often buys after the stock has fallen 15% or more.

  • Bump outward: a purchase (4)
  • Dent inward: a sale (1)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Paul BisaroDirector · MYGN · 98% match
  2. Katharine WeymouthDirector · RSG · 97% matchTheir buys since 2021: 3 of 4 beat the S&P 500
  3. Nachum ShamirDirector · MDWD · 97% match
  4. Steven D. RubinDirector · ENTX · 97% match
  5. Vickie L. CappsDirector · OFIX · 97% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 12SEC ALNYAlnylam Pharmaceuticals, Inc.First buy Buy 1,91025,959 held (+8%) $156.82 $300K -5.6%
Mar 23SEC ELVElevance Health, Inc. Sell 26218 held (−11%) $287.50 $7K +36.0%
  • Buy

    Director Amy W Schulman bought $300K of ALNY at $156.82 — first open-market purchase in our records.

Follow Amy W. Schulman

Get one email when Amy W. Schulman files a new purchase or sale. Free.

At most one email a day about Amy W. Schulman, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.